Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
Roads, Travel and Traffic
20 Years of Gas Drilling
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
20 Years of Gas Drilling
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Charles River Laboratories International, Inc. Common Stock
(NY:
CRL
)
181.24
UNCHANGED
Streaming Delayed Price
Updated: 7:00 PM EST, Feb 10, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Charles River Laboratories International, Inc. Common Stock
< Previous
1
2
...
7
8
9
10
11
12
13
14
15
...
19
20
Next >
Charles River and Aitia Enter Strategic Agreement to Utilize Logica in Discovery Programs for Neurodegenerative Diseases and Oncology
November 13, 2023
From
Charles River Laboratories International, Inc.
Via
Business Wire
Expert Ratings for Charles River
↗
November 10, 2023
Via
Benzinga
Charles River Laboratories’ Industry Experts to Present Advanced Modalities at Neuroscience 2023
November 09, 2023
From
Charles River Laboratories International, Inc.
Via
Business Wire
8 Analysts Have This to Say About Charles River
↗
October 24, 2023
Via
Benzinga
What 5 Analyst Ratings Have To Say About Charles River
↗
September 13, 2023
Via
Benzinga
Charles River Labs Q3 Revenue Jumps 4% Despite Softer Client Spending, Narrows Outlook
↗
November 08, 2023
Charles River Laboratories International Inc (NYSE: CRL) reported third-quarter (Q3) sales of $1.03 billion, an increase of 3.8% Y/Y, beating the
Via
Benzinga
Charles River Laboratories Announces Third-Quarter 2023 Results
November 08, 2023
From
Charles River Laboratories International, Inc.
Via
Business Wire
Charles River Launches Real-Time Research Model Ordering, Introducing an Important Digital Innovation to Research Models & Services Business
October 19, 2023
From
Charles River Laboratories International, Inc.
Via
Business Wire
Charles River Laboratories Schedules Third-Quarter 2023 Earnings Release and Conference Call
October 16, 2023
From
Charles River Laboratories International, Inc.
Via
Business Wire
Charles River Laboratories Provides Access to Relevant, Well-Characterized Pediatric PDX Collection for Oncology Research
October 16, 2023
From
Charles River Laboratories International, Inc.
Via
Business Wire
Charles River Laboratories Achieves 90% Renewable Electricity Globally, Announces Progress on Environmental Goals
October 11, 2023
From
Charles River Laboratories International, Inc.
Via
Business Wire
Q4 Stock Predictions: 3 S&P 500 Stocks Ready to Soar
↗
October 05, 2023
S&P 500 stocks are sliding amid a worrying interest rate environment. However, these three can buck the current downtrend.
Via
InvestorPlace
Topics
Stocks
Charles River Unveils Lentivation Platform to Expedite LVV-based Gene Therapy Manufacturing
September 26, 2023
From
Charles River Laboratories International, Inc.
Via
Business Wire
Charles River Announces Opening of RightSourceSM Laboratory, Supporting Stevenage Biocluster
September 25, 2023
From
Charles River Laboratories International, Inc.
Via
Business Wire
Charles River Laboratories International, Inc. (NYSE: CRL) Long Term Investor Alert: Investigation of Potential Wrongdoing
↗
September 22, 2023
San Diego, CA -- (SBWIRE) -- 09/22/2023 -- Certain directors of Charles River Laboratories International, Inc are under investigation concerning potential breaches of fiduciary duties.
Via
SBWire
Why Seelos Therapeutics Shares Are Trading Lower By 31%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
↗
September 21, 2023
Gainers MSP Recovery, Inc. (NASDAQ: LIFW) shares climbed 81.5% to $0.2793 after jumping 64% on Wednesday.
Via
Benzinga
Charles River Laboratories to Host Virtual Investor Day
September 20, 2023
From
Charles River Laboratories International, Inc.
Via
Business Wire
Charles River and Related Sciences Enter Multi-Program Collaboration to Pursue AI-Enabled Drug Discovery Utilizing Logica
September 14, 2023
From
Charles River Laboratories International, Inc.
Via
Business Wire
Charles River Laboratories to Present at Baird and Morgan Stanley Conferences
September 11, 2023
From
Charles River Laboratories International, Inc.
Via
Business Wire
Steer Clear of Outrageously Valued VinFast Stock. 3 EV Stocks to Buy Instead.
↗
September 06, 2023
VinFast stock has gotten inflated since its blank-check merger in early August. Check out these three EV stocks instead.
Via
InvestorPlace
Charles River and PathoQuest Announce Publication of a Head-to-Head Study Validating Proprietary Next Generation Sequencing Viral Safety Assay as a Reliable In Vitro Alternative to Animal Testing Methods
September 06, 2023
From
Charles River Laboratories International, Inc.
Via
Business Wire
WeWork's Journey From $47B Valuation To Possible Bankruptcy, Mastercard and Visa Reassess Ties with Binance Card, Hawaiian Electric Accused Of Jeopardizing Investigation Of Maui Wildfires: Today's Top Stories
↗
August 25, 2023
Wall Street Journal
Via
Benzinga
Topics
Bankruptcy
Endangered Horseshoe Crabs Vital In Medical Research, Charles River Lab Commits To Enhanced Protection
↗
August 25, 2023
Charles River Laboratories International Inc (NYSE: CRL) has joined hands with four significant entities in a pioneering move to amplify protections for the horseshoe crabs and the red knots bird...
Via
Benzinga
Charles River Laboratories Announces Plasmid Manufacturing Collaboration with Fondazione Telethon
August 24, 2023
From
Charles River Laboratories International, Inc.
Via
Business Wire
CHARLES RIVER ALERT: Bragar Eagel & Squire, P.C. is Investigating Charles River Laboratories International, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
August 22, 2023
From
Bragar Eagel & Squire, P.C.
Via
Business Wire
B of A Securities Maintains Buy Rating for Charles River: Here's What You Need To Know
↗
August 10, 2023
Via
Benzinga
US Stocks Edge Lower; Charles River Earnings Top Estimates
↗
August 09, 2023
U.S. stocks were mostly lower this morning, with the Nasdaq Composite falling more than 50 points on Wednesday. Following the market opening Wednesday, the Dow traded down 0.03% to 35,303.64 while the...
Via
Benzinga
Charles River Laboratories Announces Second-Quarter 2023 Results
August 09, 2023
From
Charles River Laboratories International, Inc.
Via
Business Wire
Lyft, Disney And 3 Stocks To Watch Heading Into Wednesday
↗
August 09, 2023
With U.S. stock futures trading slightly higher this morning on Wednesday, some of the stocks that may grab investor focus today are as follows:
Via
Benzinga
Investor Sentiment Declines After Moody's Downgrades Credit Ratings Of Banks
↗
August 09, 2023
The CNN Money Fear and Greed index showed a decline in overall sentiment among U.S. investors on Tuesday. U.S. stocks closed lower on Tuesday after Moody's downgraded the credit ratings of several US...
Via
Benzinga
< Previous
1
2
...
7
8
9
10
11
12
13
14
15
...
19
20
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at $3.75
/
week.
Subscribe Today